Biomedicine (Taipei). 2017 Jun;7(2):9. doi: 10.1051/bmdcn/2017070202. Epub 2017 Jun 14.
Genetic characteristic of class 1 integrons in proteus mirabilis isolates from urine samples.
BioMedicine
Chih-Ming Chen, Chih-Ho Lai, Hwa-Jene Wu, Lii-Tzu Wu
Affiliations
Affiliations
- Division of Infectious Disease, Department of Internal Medicine, Tungs' Taichung MetroHarbor Hospital, Taichung 433, Taiwan - Department of Health Food, Chung Chou University of Science and Technology, Changhua 510, Taiwan.
- Graduate Institute of Biomedical Sciences, Department of Microbiology and Immunology, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan - Molecular Infectious Disease Research Center, Department of Pediatrics, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Taoyuan 333, Taiwan - Graduate Institute of Basic Medical Science, School of Medicine, China Medical University, Taichung 404, Taiwan - Department of Medical Research and Department of Laboratory Medicine, China Medical University Hospital, Taichung 404, Taiwan - Department of Nursing, Asia University, Taichung 413, Taiwan.
- Department of Clinical Laboratory, Jen-Ai Hospital, Taichung 412, Taiwan.
- Graduate Institute of Basic Medical Science, School of Medicine, China Medical University, Taichung 404, Taiwan.
PMID: 28612707
PMCID: PMC5479437 DOI: 10.1051/bmdcn/2017070202
Abstract
BACKGROUND: Proteus mirabilis is an opportunistic pathogen, commonly associated with complicated urinary tract infections (UTIs). UTIs caused by multidrug-resistant Proteus mirabilis have increased worldwide. Multidrug-resistance of Gram-negative enteric bacteria is usually associated with class 1 integrons.
PURPOSES: To investigate the prevalence and characterize gene cassettes of class 1 integrons in multidrug-resistant P. mirabilis Methods: From 2006 to 2008, 314 P. mirabilis isolates from urine were collected from a regional teaching hospital. Antimicrobial resistance of the isolates was determined by disk diffusion methods. The phenotypic confirmatory test of extended-spectrum β-lactamase (ESBL) production was performed as described in the Clinical and Laboratory Standards Institute (CLSI) guideline. The genetic organization of the class 1 integron cassettes was investigated by PCR, cloning, and sequencing of the regions surrounding these genes.
RESULTS: Seventy-nine (25%, 79/314) P. mirabilis isolates were ESBL-producing and most ESBL-producing P. mirabilis were positive for bla
CONCLUSION: This study investigated the prevalence and characterized gene cassettes of class 1 integrons in MDR P. mirabilis isolates from urine samples. The frequency of gene cassettes in P. mirabilis were partially by clonal spread of the carriers and the results could provide information for effective antimicrobial therapy and infection control.
© Author(s) 2017. This article is published with open access by China Medical University.
References
- Antimicrob Agents Chemother. 2005 Nov;49(11):4771-4 - PubMed
- Int J Antimicrob Agents. 2015 Jan;45(1):84-5 - PubMed
- Int J Antimicrob Agents. 2009 Mar;33(3):216-22 - PubMed
- Clin Microbiol Infect. 2004 Apr;10(4):272-88 - PubMed
- Microbiology. 2015 Jul;161(7):1313-37 - PubMed
- Antimicrob Agents Chemother. 2000 Aug;44(8):2023-7 - PubMed
- Antimicrob Agents Chemother. 2013 Jul;57(7):2981-8 - PubMed
- Int J Antimicrob Agents. 2001 Feb;17(2):131-5 - PubMed
- Clin Microbiol Infect. 2013 Feb;19(2):E51-8 - PubMed
- J Clin Microbiol. 2000 Feb;38(2):542-6 - PubMed
- Nucleic Acids Res. 1991 Dec 25;19(24):6823-31 - PubMed
- Clin Microbiol Infect. 2008 Jan;14 Suppl 1:75-81 - PubMed
- Diagn Microbiol Infect Dis. 2006 Feb;54(2):89-94 - PubMed
- J Clin Microbiol. 2008 Sep;46(9):3080-3 - PubMed
- J Antimicrob Chemother. 2007 Jul;60(1):136-9 - PubMed
- FEMS Microbiol Rev. 2009 Jul;33(4):757-84 - PubMed
- Mol Microbiol. 1995 Feb;15(4):593-600 - PubMed
- Int J Antimicrob Agents. 2009 Apr;33(4):328-33 - PubMed
- BMC Infect Dis. 2014 Sep 05;14:486 - PubMed
- Clin Microbiol Infect. 2009 Jan;15 Suppl 1:5-10 - PubMed
- Kaohsiung J Med Sci. 2007 Jun;23(6):273-80 - PubMed
- J Antimicrob Chemother. 2005 May;55(5):639-44 - PubMed
- Int J Antimicrob Agents. 2015 May;45(5):485-90 - PubMed
- Nat Rev Microbiol. 2006 Aug;4(8):608-20 - PubMed
Publication Types